Roche
-
Roche reports positive study of Herceptin given by subcutaneous injection
Phase 3 study of a quicker route of administration shows comparable results to intravenous Herceptin.
Roche | 18 October 2011
-
Roche signs definitive agreement to acquire Anadys Pharmaceuticals
A cquisition aims to expand future treatment options for hepatitis C patients.
Roche | 17 October 2011
-
Roche’s investigational medicine T-DM1 shows improvement in progression-free survival compared to standard
First randomised trial of an antibody-drug conjugate (ADC) for metastatic breast cancer highlights importance of personalised approach to cancer care.
Roche | 26 September 2011
-
Roche named Dow Jones Sustainability Index leader in healthcare for third consecutive year
Reinforces commitment to creating long-term value for all stakeholders.
Roche | 09 September 2011
-
Roche’s investigational treatment for asthma meets primary endpoint in phase 2 study
Lebrikizumab has potential to be the first personalized treatment for asthma.
Roche | 04 August 2011
-
Roche acquires mtm laboratories, expands offering in cervical cancer testing
Roche announced that it has signed an agreement under which it will acquire 100 percent of mtm laboratories AG (mtm), a privately-held company based in Heidelberg, Germany. mtm develops in vitro diagnostics with a focus on early detection and diagnos…
Roche | 19 July 2011
-
Roche and Evotec to jointly develop biomarkers in oncology
An alliance for personalized healthcare in cancer research and development.
Roche | 24 June 2011
-
Roche Children's Walk 2011: Raising awareness for vulnerable children
Every year since 2003 Roche employees raise awareness for children in need by walking to collect donations for day-care centres in Malawi and children’s charities in their own countries. Their commitment is supported by Roche, which organises the C…
Roche | 16 June 2011
-
Nycomed to market Roche's osteoporosis treatment in Asia Pacific
Nycomed announced that it has completed the transfer of marketing authorization approvals in a number of key Asia Pacific markets for osteoporosis treatment Bonviva (Ibandronate). According to the company, the licensing agreement with Roche marks a f…
Roche | 15 June 2011
-
Bristol-Myers Squibb, Roche enter into clinical collaboration agreement
Companies will conduct an exploratory phase 1/2 study in metastatic melanoma.
Roche | 02 June 2011
